Showing results (2411-2420 of 3,017) with videos related to

Sort By:
Pageof 302
Biochemical and Biophysical Research Communications|April 6, 2018
Prevalence of NS5A resistance associated variants in NS5A inhibitor treatment failures and an effective treatment for NS5A-P32 deleted hepatitis C virus in humanized miceYuji Teraoka, Takuro Uchida, Michio Imamura, et al.
BMC Gastroenterology|October 26, 2019
Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitisHatsue Fujino, Mio Tanaka, Michio Imamura, et al.
Vaccine|March 30, 2007
Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccineLisa A Jackson, Kathleen M Neuzil, Moon H Nahm, et al.
Chronic Illness|August 22, 2022
Eliciting patients' healthcare goals and concerns: Do questions influence responses?Peter Scalia, Welmoed K van Deen, Jaclyn A Engel, et al.
Pharmacoepidemiology and Drug Safety|June 5, 2018
Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescentsMichael L Jackson, Onchee Yu, Jennifer C Nelson, et al.
Plos One|November 21, 2018
No effect of unacylated ghrelin administration on subcutaneous PC3 xenograft growth or metabolic parameters in a Rag1-/- mouse model of metabolic dysfunctionMichelle L Maugham, Inge Seim, Patrick B Thomas, et al.
Plos One|October 4, 2011
Mariprofundus ferrooxydans PV-1 the first genome of a marine Fe(II) oxidizing ZetaproteobacteriumEsther Singer, David Emerson, Eric A Webb, et al.
BMJ Public Health|June 16, 2026
Perceptions of maternity care-seeking and care-giving experiences during a health-system shock: a qualitative study with healthcare professionals and policymakers in the UK, with a focus on care for marginalised groupsLara Rowell, Tisha Dasgupta, Harriet Boulding, et al.
Diabetes Care|May 27, 2022
Association of HLA-DQ Heterodimer Residues -18β and β57 With Progression From Islet Autoimmunity to Diabetes in the Diabetes Prevention Trial-Type 1Lue Ping Zhao, Jay Skyler, George K Papadopoulos, et al.
Journal of Cutaneous Pathology|April 11, 2018
Dermatologic toxicity from immune checkpoint blockade therapy with an interstitial granulomatous patternCelestine Trinidad, Kelly C Nelson, Isabella C Glitza Oliva, et al.
Pageof 302